Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22Leukemia 18Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 7Lymphoma, B-Cell, Marginal Zone 7Lymphoma, Non-Hodgkin 6Hodgkin Disease 6Graft vs Host Disease 6Myelodysplastic Syndromes 5Leukemia, Myeloid, Acute 5Lymphoma, Mantle-Cell 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Waldenstrom Macroglobulinemia 3Multiple Myeloma 3Hematologic Neoplasms 3Carcinoma, Renal Cell 3Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, B-Cell 2Leukemia, Myelomonocytic, Chronic 2Kidney Neoplasms 2Bronchiolitis Obliterans Syndrome 2Blast Crisis 2Thrombocythemia, Essential 1Stomach Neoplasms 1Sezary Syndrome 1

Interventions

Pemetrexed 39Cisplatin 33pembrolizumab 21Nivolumab 17Carboplatin 16Ipilimumab 13Gemcitabine 10Cyclophosphamide 9fludarabine 6durvalumab 6Bevacizumab 6Radiotherapy, Intensity-Modulated 4LMB-100 4Dexamethasone 4tremelimumab 3tazemetostat 3spartalizumab 3olaparib 3niraparib 3atezolizumab 3anetumab ravtansine 3amatuximab 3Vinorelbine 3Paclitaxel 3Imatinib Mesylate 3Cerebral Decortication 3tislelizumab 2sargramostim 2fludarabine phosphate 2defactinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Mesothelioma × Pentostatin × Clear all
NCT01362790 2019-06-06

SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
55 enrolled 22 charts
GastrointestinalOther solid neoplasmThoracic

Adenocarcinoma of Lung, Mesothelioma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡